Lataa...
Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation
BACKGROUND: Dabigatran, an oral thrombin inhibitor, and rivaroxaban and apixaban, oral factor Xa inhibitors, have been found safe and effective in reducing stroke risk in patients with atrial fibrillation. We sought to compare the efficacy and safety of the 3 new agents based on data from their publ...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3471365/ https://ncbi.nlm.nih.gov/pubmed/22787066 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCOUTCOMES.112.965988 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|